A new genetic testing protocol developed in Brisbane could help identify patients at risk of age-related macular degeneration decades before symptoms appear.

A new study shows geographic atrophypatients treated monthly with the investigational drug ANX007 cut their risk of vision loss by 72%.

Australian researchers have used a gene therapy technique to suppress the production of vascular endothelial growth factor (VEGF) in human retinal cells.

New South Wales is one step closer to closing the gap in regional and remote eye care delivery, having opened the Gadigal Eye Clinic.